Myasthenia Gravis
Mr.Sachin Dwivedi
M.SC. Medical surgical Nursing
K.G.M.U Institute of Nursing ,
Lucknow
Myasthenia gravis (Ascending Disease)
Myasthenia Gravis
The name myasthenia gravis, which is Latin and
Greek in origin, means "grave, or serious, muscle
weakness.“
Autoimmune disease affecting the neuromuscular
junction.
Not a brain disorder – brain functions normally
Characterized by fluctuating muscle weakness and
fatigability
Disease may be generalized or ocular specific.
Definition
Myasthenia gravis, an autoimmune disorder
affecting the myoneural junction, is characterized
by varying degrees of weakness of the voluntary
muscles.
It is an autoimmune disorder, in which weakness
is caused by circulating antibodies that block
acetylcholine receptors at the postsynaptic
neuromuscular junction, inhibiting the excitatory
effects of the neurotransmitter acetylcholine
throughout neuromuscular junctions.
Causes
Idiopathic.
Autoantibodies that destroys acetylcholine
receptors.
Thymus tumors found in 15% of patients
Incidence
MG affects 14 per 100,000 people in the United
States
Can affect any age group
Women – peak incidence 20's to 30's
Men – peak incidence 50's to 60's
PATHOPHSIOLOGY
Resulting in voluntary muscle weakness that escalates with continued activity
Impair the ability of acetylcholine to bind to receptors.
Act against the nicotinic acetylcholine receptor
Antibodies attack Acetylcholine (ACH) receptors at the motor end plate
Development of auto- antibodies
Due to auto-immune response.
Myasthenia gravis (Ascending Disease)
CLINICAL MANIFESTATION
Affects any of the muscles that control voluntarily, certain
muscle groups are more commonly affected than others
 Eye, face, throat, neck, limb muscles
The hallmark of myasthenia gravis is fatigability
Dysarthria.
Dysphagia.
Ptosis.
Diplopia
Nasal-sounding speech
Worsening muscle weakness
DIAGNOSTIC EVALUATION
History:-
Physical examination:-
Edrophonium test (Tensilon)
Blood analysis:-
Repetitive nerve stimulation
Single-fiber electromyography (EMG)
Imaging scans:
Physical Examination
Muscle strength and tone.
Coordination.
Sense of touch
and impairment of eye movements.
Anticholinesterase test
Edrophonium chloride (Tensilon) is injected
intravenously, 2 mg at a time to a total of 10
mg. 30 seconds after injection, facial
muscle weakness and ptosis should resolve
for about 5 minutes.
This immediate improvement in muscle
strength after administration of this agent
represents a positive test and usually
confirms the diagnosis.
Blood analysis
Elevated levels of
acetylcholine
receptor antibodies.
Anti
MuSK(Muscle-
Specific Kinase)
antibody.
Repetitive Nerve stimulation
Repetitive nerve stimulation,
which repeatedly stimulates a
person’s nerves with small pulses
of electricity to tire specific
muscles.
Muscle fibers do not respond as
well to repeated electrical
stimulation.
Single-fiber electromyography
(EMG)
It considered the
most sensitive test
for myasthenia
gravis, detects
impaired nerve-to-
muscle
transmission.
Imaging scans
CT Or MRI: Its
shows thymus
enlargement.
Non-pharmacological Management
Eat small meals and snacks 5-6 times a day
Avoid using low fat or diet products when
possible.
Avoid eating lemons or tonic water.
Eat warm rather than hot food.
Runny or puree diet when swallowing is difficult.
Alternate sips of liquid to avoid food from sticking
AVOID eating chewy or dry crumbly foods
Pharmacological Management
Immunosuppressive Therapy
 Prednisone
 Azathioprine
Acetylcholinesterase Inhibitors
 First line of therapy
 Neostigmine bromide (Pyridostigmine)
 Edrophonium chloride (Tensilon)
Plasmapheresis
Immunoglobulin Therapy
Surgical management
Thymectomy: (surgical
removal of the thymus
gland) can produce
antigen-specific
immunosuppression
and result in clinical
improvement.
COMPLICATION
Myasthenic Crisis:-
A myasthenic crisis is an exacerbation of the
disease process characterized by severe
generalized muscle weakness and respiratory
and bulbar weakness that may result in
respiratory failure.
Myasthenic Crisis VS.
Cholinergic Crisis
Myasthenic Crisis
Under medication
Increased HR/BP/RR
Bowel and bladder
incontinence
Decreased urine output
Absent cough and
swallow reflex
May need mechanical
ventilation
Temporary improvement
of symptoms with
administration of
Tensilon
Cholinergic Crisis
Overmedication
Decreased BP
Abd cramps
N/V, Diarrhea
Blurred vision
Pallor
Facial muscle twitching
Constriction of pupils
Tensilon has no effect
Symptoms improve with
administration of
anticholinergics (Atropine)
Nursing Interventions
Maintain patent airway
Assess swallowing to prevent aspiration
Keep appropriate equipment available at the
bedside: Oxygen, suction, Ambu bag,
endotracheal intubation
Promote energy conservation measures
Consult Physical Therapy for medical equipment
needs (i.e.walkers, wheelchairs)
Nursing Interventions
Consult OT for assistive devices to facilitate
ADLs
Consult with speech and language therapist if
weakening facial muscles impact communication
Monitor I/O, serum albumin levels, and daily
weights
Know the signs and symptoms of both
Myasthenic Crisis
Administer Medications as per order.
Patient Teaching
Teach patient/family disease process, complications, and
treatments
Teach patient about their medications uses dosage etc.
Teach medications to use with caution that is muscle
exacerbation
 Beta blockers, calcium channel blockers, quinine, quinidine,
procainamide, some antibiotics, neuromuscular blocking agents
Prognosis
Chronic disease with periods of exacerbation and
sometimes remissions .
Disease course is highly variable.
Symptoms respond well to treatment and in most
cases the patient can live a normal or nearly
normal life.
Ocular Myasthenia has the best prognosis.
Thank
you

More Related Content

PPTX
Multiple sclerosis
PPTX
Guillain Barre syndrome (GBS) slide share
PPTX
Myasthenia gravis
PPT
Myasthenia gravis new
PPTX
Myasthenia gravis,
PPTX
Myasthenia gravis
PPTX
Myasthenia gravis
Multiple sclerosis
Guillain Barre syndrome (GBS) slide share
Myasthenia gravis
Myasthenia gravis new
Myasthenia gravis,
Myasthenia gravis
Myasthenia gravis

What's hot (20)

PPTX
Guillain-Barré syndrome (GBS)
PPTX
Bronchial asthma
PPTX
Paraplegia ppt
PPTX
Peripheral Neuropathy
PPTX
bronchitis - CHRONIC BRONCHITIS
PPTX
Epilepsy
PPTX
Bronchitis
PDF
Laryngitis
PPTX
Chorea
PPTX
Pharyngitis
PPTX
Bronchiectasis
PPTX
Seizure and epilepsy
PPTX
Cushings syndrome
PPTX
Alzheimer’s disease
PPT
Bronchiectases
PPTX
Rhinitis
PPTX
Epilepsy ppt
Guillain-Barré syndrome (GBS)
Bronchial asthma
Paraplegia ppt
Peripheral Neuropathy
bronchitis - CHRONIC BRONCHITIS
Epilepsy
Bronchitis
Laryngitis
Chorea
Pharyngitis
Bronchiectasis
Seizure and epilepsy
Cushings syndrome
Alzheimer’s disease
Bronchiectases
Rhinitis
Epilepsy ppt
Ad

Similar to Myasthenia gravis (Ascending Disease) (20)

PPTX
Myasthenia gravis
PPTX
MYASTHENIA GRAVIS.pptx
PPTX
myastheniagravisbymr-20080611443504.pptx
PPTX
Myasthenia gravis
PPTX
myasthenia gravis.pptx
PPTX
Myasthenia gravis - medical information
PPTX
Myasthenia Gravis NEUROLOGICAL DISORDER
PPT
Myasthenia gravis
PPTX
Mahareak myasthenia
PPTX
Myasthenia Gravis
PPTX
10.Mysthenia Gravis management of this conditions.pptx
PPT
myasthenia_gravis diagnosis and management
PPTX
myasthenia gravis sultan alhajali.pptx
PPT
Peripheral Neuropathies (Guillian Barre & Myasthenia Gravis)
PDF
myasthenia gravis.pdf
PPT
Myasthenia Gravis - Pathophysiology, Cl. Features, DD
PPTX
Myasthenia Gravis
PPTX
Myasthania Gravis
PPTX
myasthenia gravis ppt.pptx
PPTX
1 narrated myasthenia pp
Myasthenia gravis
MYASTHENIA GRAVIS.pptx
myastheniagravisbymr-20080611443504.pptx
Myasthenia gravis
myasthenia gravis.pptx
Myasthenia gravis - medical information
Myasthenia Gravis NEUROLOGICAL DISORDER
Myasthenia gravis
Mahareak myasthenia
Myasthenia Gravis
10.Mysthenia Gravis management of this conditions.pptx
myasthenia_gravis diagnosis and management
myasthenia gravis sultan alhajali.pptx
Peripheral Neuropathies (Guillian Barre & Myasthenia Gravis)
myasthenia gravis.pdf
Myasthenia Gravis - Pathophysiology, Cl. Features, DD
Myasthenia Gravis
Myasthania Gravis
myasthenia gravis ppt.pptx
1 narrated myasthenia pp
Ad

More from Sachin Dwivedi (9)

PPTX
Movement disorder - HUNTINGTON'S DISEASE(Chorea)
PPTX
Spinal cord injury (SCI)
PPTX
Hemodialysis and care of patients.
PPTX
Chronic Renal Failure (End Stage Renal Failure)
PPTX
Benign prostate hyperplasia (BPH)
PPTX
Nephrotic syndrome By Sachin Dwivedi
PPTX
Multiple sclerosis
PPTX
Seizures
PPTX
Heart o9
Movement disorder - HUNTINGTON'S DISEASE(Chorea)
Spinal cord injury (SCI)
Hemodialysis and care of patients.
Chronic Renal Failure (End Stage Renal Failure)
Benign prostate hyperplasia (BPH)
Nephrotic syndrome By Sachin Dwivedi
Multiple sclerosis
Seizures
Heart o9

Recently uploaded (20)

PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PPT
fiscal planning in nursing and administration
PPTX
Peripheral Arterial Diseases PAD-WPS Office.pptx
PPTX
FORENSIC MEDICINE and branches of forensic medicine.pptx
PPTX
Biostatistics Lecture Notes_Dadason.pptx
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
Surgical anatomy, physiology and procedures of esophagus.pptx
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PPSX
Man & Medicine power point presentation for the first year MBBS students
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PPTX
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
PPTX
IMMUNITY ... and basic concept mds 1st year
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PDF
Demography and community health for healthcare.pdf
PPTX
presentation on causes and treatment of glomerular disorders
PPTX
ACUTE PANCREATITIS combined.pptx.pptx in kids
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPTX
Nutrition needs in a Surgical Patient.pptx
Cranial nerve palsies (I-XII) - AMBOSS.pdf
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
fiscal planning in nursing and administration
Peripheral Arterial Diseases PAD-WPS Office.pptx
FORENSIC MEDICINE and branches of forensic medicine.pptx
Biostatistics Lecture Notes_Dadason.pptx
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Surgical anatomy, physiology and procedures of esophagus.pptx
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
Man & Medicine power point presentation for the first year MBBS students
ENT-DISORDERS ( ent for nursing ). (1).p
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
IMMUNITY ... and basic concept mds 1st year
Phamacology Presentation (Anti cance drugs).pptx
Demography and community health for healthcare.pdf
presentation on causes and treatment of glomerular disorders
ACUTE PANCREATITIS combined.pptx.pptx in kids
periodontaldiseasesandtreatments-200626195738.pdf
Nutrition needs in a Surgical Patient.pptx

Myasthenia gravis (Ascending Disease)

  • 1. Myasthenia Gravis Mr.Sachin Dwivedi M.SC. Medical surgical Nursing K.G.M.U Institute of Nursing , Lucknow
  • 3. Myasthenia Gravis The name myasthenia gravis, which is Latin and Greek in origin, means "grave, or serious, muscle weakness.“ Autoimmune disease affecting the neuromuscular junction. Not a brain disorder – brain functions normally Characterized by fluctuating muscle weakness and fatigability Disease may be generalized or ocular specific.
  • 4. Definition Myasthenia gravis, an autoimmune disorder affecting the myoneural junction, is characterized by varying degrees of weakness of the voluntary muscles. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction, inhibiting the excitatory effects of the neurotransmitter acetylcholine throughout neuromuscular junctions.
  • 5. Causes Idiopathic. Autoantibodies that destroys acetylcholine receptors. Thymus tumors found in 15% of patients
  • 6. Incidence MG affects 14 per 100,000 people in the United States Can affect any age group Women – peak incidence 20's to 30's Men – peak incidence 50's to 60's
  • 7. PATHOPHSIOLOGY Resulting in voluntary muscle weakness that escalates with continued activity Impair the ability of acetylcholine to bind to receptors. Act against the nicotinic acetylcholine receptor Antibodies attack Acetylcholine (ACH) receptors at the motor end plate Development of auto- antibodies Due to auto-immune response.
  • 9. CLINICAL MANIFESTATION Affects any of the muscles that control voluntarily, certain muscle groups are more commonly affected than others  Eye, face, throat, neck, limb muscles The hallmark of myasthenia gravis is fatigability Dysarthria. Dysphagia. Ptosis. Diplopia Nasal-sounding speech Worsening muscle weakness
  • 10. DIAGNOSTIC EVALUATION History:- Physical examination:- Edrophonium test (Tensilon) Blood analysis:- Repetitive nerve stimulation Single-fiber electromyography (EMG) Imaging scans:
  • 11. Physical Examination Muscle strength and tone. Coordination. Sense of touch and impairment of eye movements.
  • 12. Anticholinesterase test Edrophonium chloride (Tensilon) is injected intravenously, 2 mg at a time to a total of 10 mg. 30 seconds after injection, facial muscle weakness and ptosis should resolve for about 5 minutes. This immediate improvement in muscle strength after administration of this agent represents a positive test and usually confirms the diagnosis.
  • 13. Blood analysis Elevated levels of acetylcholine receptor antibodies. Anti MuSK(Muscle- Specific Kinase) antibody.
  • 14. Repetitive Nerve stimulation Repetitive nerve stimulation, which repeatedly stimulates a person’s nerves with small pulses of electricity to tire specific muscles. Muscle fibers do not respond as well to repeated electrical stimulation.
  • 15. Single-fiber electromyography (EMG) It considered the most sensitive test for myasthenia gravis, detects impaired nerve-to- muscle transmission.
  • 16. Imaging scans CT Or MRI: Its shows thymus enlargement.
  • 17. Non-pharmacological Management Eat small meals and snacks 5-6 times a day Avoid using low fat or diet products when possible. Avoid eating lemons or tonic water. Eat warm rather than hot food. Runny or puree diet when swallowing is difficult. Alternate sips of liquid to avoid food from sticking AVOID eating chewy or dry crumbly foods
  • 18. Pharmacological Management Immunosuppressive Therapy  Prednisone  Azathioprine Acetylcholinesterase Inhibitors  First line of therapy  Neostigmine bromide (Pyridostigmine)  Edrophonium chloride (Tensilon) Plasmapheresis Immunoglobulin Therapy
  • 19. Surgical management Thymectomy: (surgical removal of the thymus gland) can produce antigen-specific immunosuppression and result in clinical improvement.
  • 20. COMPLICATION Myasthenic Crisis:- A myasthenic crisis is an exacerbation of the disease process characterized by severe generalized muscle weakness and respiratory and bulbar weakness that may result in respiratory failure.
  • 21. Myasthenic Crisis VS. Cholinergic Crisis Myasthenic Crisis Under medication Increased HR/BP/RR Bowel and bladder incontinence Decreased urine output Absent cough and swallow reflex May need mechanical ventilation Temporary improvement of symptoms with administration of Tensilon Cholinergic Crisis Overmedication Decreased BP Abd cramps N/V, Diarrhea Blurred vision Pallor Facial muscle twitching Constriction of pupils Tensilon has no effect Symptoms improve with administration of anticholinergics (Atropine)
  • 22. Nursing Interventions Maintain patent airway Assess swallowing to prevent aspiration Keep appropriate equipment available at the bedside: Oxygen, suction, Ambu bag, endotracheal intubation Promote energy conservation measures Consult Physical Therapy for medical equipment needs (i.e.walkers, wheelchairs)
  • 23. Nursing Interventions Consult OT for assistive devices to facilitate ADLs Consult with speech and language therapist if weakening facial muscles impact communication Monitor I/O, serum albumin levels, and daily weights Know the signs and symptoms of both Myasthenic Crisis Administer Medications as per order.
  • 24. Patient Teaching Teach patient/family disease process, complications, and treatments Teach patient about their medications uses dosage etc. Teach medications to use with caution that is muscle exacerbation  Beta blockers, calcium channel blockers, quinine, quinidine, procainamide, some antibiotics, neuromuscular blocking agents
  • 25. Prognosis Chronic disease with periods of exacerbation and sometimes remissions . Disease course is highly variable. Symptoms respond well to treatment and in most cases the patient can live a normal or nearly normal life. Ocular Myasthenia has the best prognosis.